Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction
US11261434B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 4, 2015 |
| Grant date | Mar 1, 2022 |
| Priority date | — |
| Expiry date | May 26, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compositions and methods useful for the treatment and prevention of conditions associated with myocardial infarction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.